T1	intervention 0 18	Omega-3 fatty acid
T2	condition 61 99	aromatase inhibitor-related arthralgia
T3	eligibility 596 650	Post-menopausal women with stage I-III BC taking an AI
T5	control 692 699	placebo
T8	total-participants 914 917	249
T10	outcome 1067 1100	BPI worst pain scores at 24 weeks
T12	iv-cont-mean 1124 1128	4.36
T13	cv-cont-mean 1133 1137	5.70
T14	outcome 1001 1015	obese patients
T15	outcome 1164 1182	non-obese patients
T16	iv-cont-mean 1254 1258	5.27
T17	cv-cont-mean 1263 1267	4.58
T4	outcome 1349 1365	BPI average pain
T6	outcome 1370 1394	pain interference scores
